Sort   by:  
 Page size 
ProteomicsCharacterization of ultraID for PDB-MS
Comparison of BioID (24h labeling) and ultraID (10 min labeling) for PDB-MS (POI = Ago2, control protein = Rab11). 4 biological replicates per condition.
ORGANISM(S): Homo sapiens (Human) 
2022-07-05 | PXD026719 | Pride
Bioid pdb 
ProteomicsCOPI membrane interactome by ultraID-MS
Analysis of a membrane-bound COPI interactome by comparing gammaCOP-ultraID datasets with or without incubation with brefeldin A (POI = gamma1COP or gamma2COP, control protein = Ago2). Three biological replicates per condition.
ORGANISM(S): Mus musculus (Mouse) 
2022-07-05 | PXD026715 | Pride
Ultraid pdb copi 
ProteomicsCharacterization of ultraID for PDB-MS
Comparison of TurboID (no labeling) and ultraID (no labeling) for PDB-MS (POI = Ago2, control protein = Rab11), 3 to 4 biological replicates per condition. PDB-MS with TurboID (10 min labeling) (POI = Ago2, control protein = Rab11). 4 biological replicates per condition.
ORGANISM(S): Homo sapiens (Human) 
2022-07-05 | PXD032979 | Pride
Bioid ultraid turboid pdb-ms 
UnknownImpact of Glutathione on Wines Oxidative Stability: A Combined Sensory and Metabolomic Study.
Not available
S-EPMC6002495 | biostudies-literature
ProteomicsDIA of Gasdermin-D knockout and cuprizone treated mouse brain tissue
Data-independent acquisition (DIA) of four replicates of mouse brain tissue lysate for each of the four conditions Gasdermin-D WT, Gasdermin-D KO, Gasdermin-D WT treated with cuprizone, and Gasdermin-D KO treated with cuprizone.
ORGANISM(S): Mus Musculus (ncbitaxon:10090) 
2023-02-02 | MSV000091185 | MassIVE
Genomicsena-DATASET-ICM-15-06-2017-11:25:49:785-1367 - samples
Description not provided
EGAD00001003382 | EGA
Genomicsena-DATASET-ICM-15-06-2017-21:23:23:822-1522 - samples
Description not provided
EGAD00001003387 | EGA
GenomicsSame-day genomic and epigenomic diagnosis of brain tumors using realtime nanopore sequencing
Molecular classification of cancer has entered clinical routine to inform diagnosis, prognosis and treatment decisions. At the same time, new tumor entities have been identified that cannot be defined histologically. For central nervous systems tumors, the current World Health Organization classific...
EGAS00001002213 | EGA
Unknown20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
Not available
S-EPMC5734609 | biostudies-literature
UnknownInterlaboratory Study for Characterizing Monoclonal Antibodies by Top-Down and Middle-Down Mass Spectrometry.
Not available
S-EPMC7539639 | biostudies-literature
Sort   by:  
 Page size